EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature

Hilde K Gjelberg, Lars Helgeland, Knut Liseth, Francesca Micci, Miriam Sandnes, Hege G Russnes, Håkon Reikvam iD

Current Oncology · 2023

DOI: 10.3390/curroncol30110727 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Hilde K Gjelberg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Haukeland University Hospital, N-5021 Bergen, Norway. Hauptthemen laut MEDLINE: Leukemia, Prolymphocytic, Leukemia, Prolymphocytic, T-Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T-prolymphocytic leukemia (T-PLL) is a rare malignancy of mature T-cells with distinct clinical, cytomorphological, and molecular genetic features. The disease typically presents at an advanced stage, with marked leukocytosis, B symptoms, hepatosplenomegaly, and bone marrow failure. It usually follows an aggressive course from presentation, and the prognosis is often considered dismal; the median overall survival is less than one year with conventional chemotherapy. This case report describes a patient with T-PLL who, after an unusually protracted inactive phase, ultimately progressed to a highly invasive, organ-involving disease. After initial treatments failed, a novel treatment approach resulted in a significant response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, ProlymphocyticLeukemia, Prolymphocytic, T-CellHumansAlemtuzumab

Stichwörter der Autor:innen

ATMJAK/STATT-prolymphocytic leukemia (T-PLL)TCL1alemtuzumabpentostatin

Substanzen

Alemtuzumab

Autor:innen und Institutionen

  • Department of Pathology, Haukeland University Hospital, N-5021 Bergen, Norway.
  • Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
  • Department of Immunology and Transfusion Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.
  • Section for Cancer Cytogenetics, Institute of Cancer Genetics and Informatics, Oslo University Hospital, N-0424 Oslo, Norway.
  • Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.
  • Department of Pathology, Oslo University Hospital, N-0424 Oslo, Norway.

ORCID-Profile: Håkon Reikvam

Zitieren

APA

Gjelberg, H. K., Helgeland, L., Liseth, K., Micci, F., Sandnes, M., Russnes, H. G., & Reikvam, H. (2023). Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature. Current Oncology. https://doi.org/10.3390/curroncol30110727

Vancouver

Gjelberg HK, Helgeland L, Liseth K, Micci F, Sandnes M, Russnes HG, et al. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature. Current Oncology. 2023. doi:10.3390/curroncol30110727

BibTeX
@article{Gjelberg2023,
  author = {Gjelberg, Hilde K and Helgeland, Lars and Liseth, Knut and Micci, Francesca and Sandnes, Miriam and Russnes, Hege G and Reikvam, Håkon},
  title = {Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30110727}
}
Kostenlos starten →